Overall rank by patents
#28,282
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Biomet Microfixation, Llc
USPTO PatentsView assignee record - 9 granted patents across 3 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
9
Total patents granted
3
CPC technology areas
20.2
Avg claims per patent
+25%
5-year filing velocity
The verdict
Biomet holds 9 US patents across 3 technology areas, rank #28,282 of 50,000 tracked assignees.
- #28,282
- of 50,000 US assignees by volume
- Top 21%
- by Innovation Score (46.2/100)
- 20.2
- avg claims per patent
- +25%
- filing velocity, last 5 yrs
Portfolio overview
Biomet Microfixation, Llc has been granted 9 US utility patents between 2015 and 2025, placing Biomet Microfixation, Llc at rank #28,282 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Biomet Microfixation, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Biomet sits between Binatone Electronics International Limited (9 patents, rank #28,278) and Bird Home Automation Gmbh (9 patents, rank #28,286) - the closest US assignees by grant volume. The composite Innovation Score of 46.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 4 in the 2015–2019 window, a +25% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Biomet Microfixation, Llc's 20.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Biomet Microfixation, Llc against peers pursuing similar technology classes.
Who files at Biomet's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Binatone Internat…
Binatone Electronics International Limited
9 patents
- Bioage Labs
BioAge Labs, Inc.
9 patents
- Biolegend
BioLegend, Inc.
9 patents
- Biopharmx
BioPharmX, Inc.
9 patents
- Bioness Neuromodu…
Bioness Neuromodulation Ltd.
9 patents
- Bioserenity
Bioserenity
9 patents
- Biotie Therapies
Biotie Therapies, Inc.
9 patents
- Bird Home Automat…
Bird Home Automation GmbH
9 patents
- Biomet Microfixat… ◀
Biomet Microfixation, LLC
9 patents
What this shows Biomet holds 9 patents at rank #28,282, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biomet
By rank, the assignees closest to #28,282 in granted patent volume.
- Binatone Electronics International Limited #28,278 · 9 patents
- Bioage Labs, Inc. #28,279 · 9 patents
- Biolegend, Inc. #28,280 · 9 patents
- Biopharmx, Inc. #28,281 · 9 patents
- Bioness Neuromodulation Ltd. #28,283 · 9 patents
- Bioserenity #28,284 · 9 patents
- Biotie Therapies, Inc. #28,285 · 9 patents
- Bird Home Automation Gmbh #28,286 · 9 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Biomet's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Biomet's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 21% higher than 79% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 22.2% |
| 2016 | 2 | 22.2% |
| 2024 | 3 | 33.3% |
| 2025 | 2 | 22.2% |
Which technologies does Biomet Microfixation, Llc patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Growing
Frequently Asked Questions
How many patents does Biomet Microfixation, Llc hold?
Biomet Microfixation, Llc holds 9 US granted patents filed between 2015 and 2025, spanning 3 technology areas.
What is Biomet Microfixation, Llc's Innovation Score?
Biomet Microfixation, Llc has an Innovation Score of 46.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Biomet Microfixation, Llc focus on?
Biomet Microfixation, Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 9 patents. The company has filed patents in 3 CPC subclasses total.
Is Biomet Microfixation, Llc's patent filing rate increasing or decreasing?
Biomet Microfixation, Llc's recent filing velocity is +25% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Biomet Microfixation, Llc's patents?
Biomet Microfixation, Llc's patents average 20.2 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Biomet Microfixation, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Biomet's 9 grants land it in the top 21% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Biomet ranks #28,282 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.